Cerimon Pharmaceuticals, Inc.'s strategic approach to pipeline development is to acquire, develop and commercialize late-stage or marketed products through partnerships with pharmaceutical companies. Cerimon’s unique tripartite approach helps meet the Company’s goal of becoming a leading specialty biopharmaceutical company.

Cerimon’s Strategic Approach to Pipeline Development

New Markets: Develop and commercialize late-stage or marketed drugs not currently available in North America but marketed in other countries

New Indications: In-license marketed drugs for development in new targeted indications worldwide

New Opportunities: In-license late stage compounds in key therapeutic areas through partnerships